Optimal treatment of OCT defined calcific nodules. Procedural and clinical outcomes of orbital atherectomy versus intravascular lithotripsy @DoosupShin @DakroubAH @OKhaliqueMD @MaeharaAkiko @Eshlof @DrAllenJ @ZiadAliNYC https://t.co/tU79TXVx44

CLEAR-IE - largest multicenter registry on percutaneous mechanical aspiration in R infective endocarditis now published in @JACCJournals - high procedural success, 93% neg blood cx, adverse events likely related to complications from IE esp hypoxia and shock - Prospective studies

@JWMoses @DoosupShin @DrAllenJ @ESHLOF @OKhaliqueMD @ziadalinyc @CircIntv

Orbital Atherectomy Versus Intravascular Lithotripsy in Patients With Calcified Nodules @JWMoses @DoosupShin @DrAllenJ @EShlof @OKhaliqueMD @ziadalinyc #ComplexPCI #OCT #Atherectomy #CoronaryIVL #Calcium #AHAJournals Read in @CircIntv: https://t.co/ldGk7vyi7j

The current state of simultaneous heart-liver transplantation in the United States @SaraHassanMD @LisaVWMD @MaryjaneFarrMD @TCotterMD Read in @amjtransplant: https://t.co/M8wQFLdALZ

📰Cigarette smoke extract induces p38-mediated expression and ROS/rho-mediated translocation of alpha 2C adrenoceptor in human microvascular smooth muscle cells 🔗 https://t.co/R8uuh3Ad10 @ayahmatar @DakroubAH @ElsevierConnect @ELS_Cardiology #Cardiology #CardioTwitter

Stent-edge calcium may predispose to the development of calcific nodules and increased cardiac events @djc795 @DoosupShin @DrAllenJ @cardio_dr_ys @EShlof @OKhaliqueMD @DakroubAli_ @ziadalinyc #AHAJournals https://t.co/XNtlZKOIjM

Our letter to the editor: Validity of propensity-matched observational studies in comparative effectiveness studies of TAVR vs SAVR. @ZaidAlMarzooq #TAVR #SAVR @AATSHQ Read in #JTCVS: https://t.co/e4X5tq2e86

ECLIPSE publ today in Lancet. In 2005 pts with severe lsn calcification by angiography that did not absolutely require atherectomy, there were no sig differences in acute MSA or 1-year TVF with orbital atherectomy vs. balloon pre-dilatation. Free link: https://t.co/CUwcO8zNL1

🔬 New in #JACCINT! A revised #OCT-derived calcium score predicts stent underexpansion in severely calcified lesions 🫀💡. This reliable tool helps identify at-risk lesions, improving stent deployment outcomes 📊 Read more 👉 https://t.co/e9bl3VGJFf

Free until April 1: Late Clinical Outcomes of BEV in Small Annuli (PARTNER Trials) https://t.co/WT625B1S9O See also https://t.co/GbQ35n2zC6 https://t.co/zsr9yA0fMk https://t.co/bYAAdbATCe https://t.co/MEHXY6U9oe @JACCJournals @ACCinTouch @PPibarot @djc795 @ESC_Journals

More class 1A for IVUS/OCT! ACS with stent implantation in the LMCA or in complex lesions. Routine systematic use = improved prognosis @h_evald @DrPeterOKane @jcspratt @mirvatalasnag @mmamas1973 @DrKoltowski @BURZOTTA_F

#TAVR 1 yr safety outcomes from ACURATE IDE Trial RCT - Acurate vs Evolut vs SAPIEN S3 had lower CV death, disabling stroke and PVL compared to other 2 devices. For years, we have been asking for comparative data from TVT registry. Where is the transparency? Time to open it up!

Amazing work in @JACCJournals Photon counting CT is bananas. Positive predictive value 83.3% vs 63.0%! Picture below captures it Potential game changer for most appropriate diagnosis, referral, and higher value care https://t.co/fthUHVSypu

@JAMA_current @JAMACardio @acamajmd @manishvinayak @georgedangas @DLBHATTMD @Drroxmehran @MyJSCAI @SCAI @SandeepNathanMD @SVRaoMD @yadersandoval @AmirLotfi9 @ziadalinyc @PCRonline @CCuesta2 @bruno_scheller @baumbach_a @sbrugaletta @azeemlatib @TCT_ME_ @crfheart @mirvatalasnag @AlkashkariWail @TCTConference @BakhshiHooman @tristonsmithmd @Hragy @chadialraies @evandrofilhobr @purviparwani @mmamas1973 @minhaskh @CASivaram1 This is also SRMA @ccijournal PCB vs SCB It’s conclude that: 🔹Among patients undergoing DCB-only PCI, the risk of TLF was similar during 9-12 months of follow up after PCB and SCB treatment. 🔹However, the MLD was larger favoring PCB over SCB on follow- up angiography.

Do you have a TAVR preference? Self-Expanding vs Balloon Expandable TAVR. @DakroubAH @SarahMalik05 @sellers_steph @David_Meier_ @djc795 @CathElectroSurg #cardiotwitter #AHAJournals https://t.co/Z6am7JYlrh

No difference in bioprosthetic valve failure (using SMART trial definitions) when comparing Sapien Resilia to Evolut Fx in our propensity matched study. More insights into the Resilia hemodynamics story. @OKhaliqueMD @ziadalinyc @OPCILive @amrabbasmd

Early Hemodynamic Performance of Evolut FX vs. SAPIEN 3 Ultra Resilia @SarahMalik05 @sellers_steph @David_Meier_ @djc795 @CathElectroSurg #SAPIEN3Ultra #Resilia #EvolutFX #TAVR #cardiotwitter #AHAJournals @CircIntv Read in https://t.co/qRXb5IWnO5

#FeatureFriday: @DakroubAH, @CathElectroSurg et al recently published an invited expert opinion article on devices and approaches for leaflet modification. Read for free in #JTCVS Structural and Endovascular: https://t.co/zaoboNdrA2

#TCT2024 in case you missed it! EARLY TAVR meets primary endpoint driven by Unplanned CV Hospitalization. Also prevents ⬇️ QoL! https://t.co/TtwC0AijM9 @NEJM @TCTMD